Rhinobest-M Tablet
By Rhinobest-M
Rx
10 Tablet in a Strip
Composition
Levocetirizine(5mg) + Montelukast(10mg)
Manufacturer - Avonic Life Sciences
Kuldeep Nagar, Ambala Cantt. Haryana
Expires on or after
June, 2025
When using Rhinobest-M Tablet, it is important to use caution if you have severe liver disease. Your doctor may need to adjust the dosage of the medication in such cases. It is advisable to consult with your healthcare provider before starting or changing the dosage of Rhinobest-M Tablet if you have severe liver issues. There is limited information available regarding the use of this medication in patients with severe liver disease. However, no dose adjustment is typically needed for individuals with mild to moderate liver disease. It is essential to follow your doctor's guidance closely to ensure the safe and effective use of Rhinobest-M Tablet.
Caution should be taken when using Rhinobest-M Tablet in patients with kidney disease. Dose adjustment may be necessary. Avoid use in severe kidney disease. Consult your doctor for guidance.
When taking Rhinobest-M Tablet, it is important to be cautious when consuming alcohol. It is advised to consult your doctor regarding alcohol consumption while on this medication.
When taking Rhinobest-M Tablet, be cautious as it may reduce alertness, cause vision changes, or induce drowsiness and dizziness. Avoid driving if experiencing these effects.
During pregnancy, it is generally believed that Rhinobest-M Tablet is safe to use as it has shown minimal adverse effects in animal studies. However, there is limited research on its effects in humans.
Rhinobest-M Tablet is not recommended for use during breastfeeding as it may be toxic to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹125
Inclusive of all taxes
Content verified by
Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024